Apnimed, Inc.
APMD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001745648
In the last 90 days, Apnimed, Inc. insiders filed 2 open-market purchases and 0 sales; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysLast 90 days, $5.20M in total
- 2
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding APMD, Q2 2026
No superinvestor reported holding APMD at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Apnimed, Inc. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 (view filing)4:18 PM ET | Aug 3 | 2 days | Morningside Venture Investments Ltd10% Owner | PPurchase | +312.5K | $16.00 | +$5.00M | +4.6%7.15M after | |
| Aug 3, 2026 (view filing)4:01 PM ET | Aug 3 | Same day | Sekhri Paul JDirector | PPurchase | +12.5K | $16.00 | +$200.0K | New position12.5K after |
Top 10 13F holders, Q2 2026
The largest institutional positions in Apnimed, Inc. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding APMD in 13F filings for Q2 2026.